Evidence map›Paper›PMID 34068131›Full record

ArticleSensors (Basel, Switzerland)2021

e-CoVig: A Novel mHealth System for Remote Monitoring of Symptoms in COVID-19.

Afonso Raposo, Luis Marques, Rafael Correia, Francisco Melo, João Valente, Telmo Pereira, Luis Brás Rosário, Filipe Froes, João Sanches, Hugo Plácido da Silva

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Respinos: A Portable Device for Remote Vital Signs Monitoring of COVID-19 Patients.IEEE transactions on biomedical circuits and systems · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Afonso RaposoInstituto Superior Técnico (IST), Av. Rovisco Pais n. 1, 1049-001 Lisboa, Portugal.ORCID 0000-0002-0161-5248
Luis MarquesBrainAnswer, Lda., Rua Engenheiro Pires Marques, Lote 61, n. 5-Dto, 6000-406 Castelo Branco, Portugal.
Rafael CorreiaInstituto Superior Técnico (IST), Av. Rovisco Pais n. 1, 1049-001 Lisboa, Portugal.
Francisco MeloInstituto Superior Técnico (IST), Av. Rovisco Pais n. 1, 1049-001 Lisboa, Portugal.
João ValenteBrainAnswer, Lda., Rua Engenheiro Pires Marques, Lote 61, n. 5-Dto, 6000-406 Castelo Branco, Portugal.
Telmo PereiraLaboratory for Applied Health Research (LabinSaúde), Polytechnic Institute of Coimbra, Coimbra Health School, Rua 5 de Outubro-SM Bispo, Apartado 7006, 3046-854 Coimbra, Portugal.ORCID 0000-0001-9119-7774
Luis Brás RosárioCentro Cardiovascular da Universidade de Lisboa (CCUL), Faculdade de Medicina da Universidade de Lisboa (FMUL), Av. Prof. Egas Moniz MB, 1649-028 Lisboa, Portugal.
Filipe FroesHospital Pulido Valente Intensive Care Unit, Alameda das Linhas de Torres, 117, 1769-001 Lisboa, Portugal.ORCID 0000-0003-4135-6022
João SanchesInstituto Superior Técnico (IST), Av. Rovisco Pais n. 1, 1049-001 Lisboa, Portugal.ORCID 0000-0001-9089-2740
Hugo Plácido da SilvaInstituto Superior Técnico (IST), Av. Rovisco Pais n. 1, 1049-001 Lisboa, Portugal.ORCID 0000-0001-6764-8432

Funding

FCT/MCTES UIDB/50008/2020 NICE-HOMEFundação para a Ciência e a Tecnologia 255_596880547 e-CoVigIT - Instituto de Telecomunicações BI/No. 13 - 19/05/2020
6 · The paper itself

Abstract

In 2019, a new virus, SARS-CoV-2, responsible for the COVID-19 disease, was discovered. Asymptomatic and mildly symptomatic patients were forced to quarantine and closely monitor their symptoms and vital signs, most of the time at home. This paper describes e-CoVig, a novel mHealth application, developed as an alternative to the current monitoring paradigm, where the patients are followed up by direct phone contact. The e-CoVig provides a set of functionalities for remote reporting of symptoms, vital signs, and other clinical information to the health services taking care of these patients. The application is designed to register and transmit the heart rate, blood oxygen saturation (SpO2), body temperature, respiration, and cough. The system features a mobile application, a web/cloud platform, and a low-cost specific device to acquire the temperature and SpO2. The architecture of the system is flexible and can be configured for different operation conditions. Current commercial devices, such as oximeters and thermometers, can also be used and read using the optical character recognition (OCR) functionality of the system. The data acquired at the mobile application are sent automatically to the web/cloud application and made available in real-time to the medical staff, enabling the follow-up of several users simultaneously without the need for time consuming phone call interactions. The system was already tested for its feasibility and a preliminary deployment was performed on a nursing home showing promising results.

Indexed as

COVID-19Mobile ApplicationsTelemedicineHumansQuarantineSARS-CoV-2COVID-19mHealthpulse oximetrytelemedicinetemperature

Identifiers

PMID34068131
PMCPMC8152780

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.